GLP1R and type 2 diabetes mellitus: A double-blind, randomized, placebo- controlled, multiple ascending-dose trial to determine the tolerability, pharmacokinetics, and pharmacodynamics of the GLP-1 receptor agonist efpeglenatide in adult subjects with T2DM on stable metformin therapy